XML 51 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8

Revenues (Tables)

6 Months Ended

Jun. 30, 2014

Segment Reporting [Abstract]

Summary of net revenue

The Company’s net revenues consisted of the following for the three and six months ended June 30, 2014 and 2013:

	Three months ended June 30,								Six months ended June 30,
	2014				2013				2014				2013
Products:
Acetadote	$	3,063,819			$	4,146,974			$	5,784,905			$	11,398,968
Omeclamox-Pak	1,344,869				—				2,484,290
Kristalose	3,559,313				2,041,043				6,935,370				4,158,293
Vaprisol	1,071,433				—				1,369,765
Caldolor	626,684				615,547				1,129,082				1,025,971
Other	84,050				277,524				140,000				755,988
Total net revenues	$	9,750,168			$	7,081,088			$	17,843,412			$	17,339,220

X

- Definition

Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 280

-SubTopic 10

-Section 50

-Paragraph 40

-URI http://asc.fasb.org/extlink&oid=6534315&loc=d3e9031-108599

+ Details

Name:	us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix:	us-gaap_
Data Type:	nonnum:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Details

Name:	us-gaap_SegmentReportingAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration